SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1074248408329860v1
14/1/68    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zandbergen, H. R.
Right arrow Articles by Hofstra, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zandbergen, H. R.
Right arrow Articles by Hofstra, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Macrophage Depletion in Hypertensive Rats Accelerates Development of Cardiomyopathy

Harmen R. Zandbergen, MD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands, University of California Irvine, School of Medicine, Irvine, California

Umesh C. Sharma, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Sudhir Gupta, MD, PhD

University of California Irvine, School of Medicine, Irvine, California, sgupta{at}uci.edu

Johan W. H. Verjans, MD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands, University of California Irvine, School of Medicine, Irvine, California

Susanne van den Borne, MD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands, University of California Irvine, School of Medicine, Irvine, California

Saraswati Pokharel, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Thomas van Brakel, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Adriaan Duijvestijn, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Nico van Rooijen, PhD

Faculty of Medicine, Vrije Universiteit, Amsterdam, Netherlands

Jos G. Maessen, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Chris Reutelingsperger, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Yigal M. Pinto, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Jagat Narula, MD, PhD

University of California Irvine, School of Medicine, Irvine, California

Leo Hofstra, MD, PhD

University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

Inflammation contributes to the process of ventricular remodeling after acute myocardial injury. To investigate the role of macrophages in the chronic process of cardiac remodeling, they were selectively depleted by intravenous administration of liposomal clodronate in heart failure—prone hypertensive Ren-2 rats from the age of 7 until 13 weeks. Plain liposomes were used for comparison. Liposomal clodronate treatment reduced the number of blood monocytes and decreased the number of macrophages in the myocardium. Compared to plain liposomes, liposomal clodronate treatment rapidly worsened left ventricular ejection function in hypertensive rats. Liposomal clodronate— treated Ren-2 rat hearts showed areas of myocyte loss with abundant inflammatory cell infiltration, predominantly comprising CD4 positive T lymphocytes. The current study showed that lack of macrophages was associated with earlier development of myocardial dysfunction in hypertensive rats. Modulation of macrophage function may be of value in the evolution of cardiomyopathy.

Key Words: hypertension • inflammation • ventricular remodeling • heart failure

This version was published on March 1, 2009

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 14, No. 1, 68-75 (2009)
DOI: 10.1177/1074248408329860


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Apostolakis, G. Y.H. Lip, and E. Shantsila
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
Cardiovasc Res, October 28, 2009; (2009) cvp327v2.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. A. de Boer, A. A. Voors, P. Muntendam, W. H. van Gilst, and D. J. van Veldhuisen
Galectin-3: a novel mediator of heart failure development and progression
Eur J Heart Fail, September 1, 2009; 11(9): 811 - 817.
[Abstract] [Full Text] [PDF]



Advertisement